Biotech

Prana's PBT2 Presented at the Huntington's Disease Society of America National Convention

MELBOURNE, AUSTRALIA: Prana's 'Reach2HD' Phase II Trial on Track ...

Prima BioMed Ltd Shareholders' Briefing Webcast & Dial In Details

SYDNEY, AUSTRALIA: ...

Emerald Bio Announces Unprecedented Multi-Target 3D Structural Biology Success

BEDFORD, MA: ...

Foamtec Introduces Sahara Corrosion Cleaning System(SM)

OCEANSIDE, CA: ...

Pharma-Biotech Capital Construction Investment Mid-Year Snapshot: 2012 Project Starts Near $15 Billion, an Industrial Info News Alert

SUGAR LAND, TX: ...

New Epidemiological Data Provide Additional Safety Evidence for Lantus(R)

PARIS, FRANCE: No Increased Risk of Cancer Found With Lantus(R) in New European and U.S. Observational Studies ...

Sanofi Announces Results of ORIGIN, the World's Longest and Largest Randomized Clinical Trial in Pre- and Early Diabetes

PARIS, FRANCE: ...

Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose

PARIS, FRANCE: Lixisenatide With Basal Insulin Helped Type 2 Diabetes Patients With Uncontrolled HbA1c Achieve Target Blood Glucose Levels; Lixisenatide Marketing Authorization Application Submitted to European Medi ...

Sunshine Heart Receives Health Canada Approval to Modify Its Ongoing Investigational Study to Use the Next Generation C-Pulse(R) System Driver

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: ...

Maxxam Analytics Acquires Becquerel Laboratories

MISSISSAUGA, ONTARIO: ...